Disclosure Of Income Tax [Text Block]

Mithra Pharmaceuticals S.A. - Filing #3183075

Concept 2022-01-01 to
2022-12-31
As at
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
Disclosure of income tax [text block]
Major components of tax expense (income) [abstract]
Tax expense (income)
48 139 EUR
6 895 EUR
Disclosure of temporary difference, unused tax losses and unused tax credits [text block]
Disclosure of temporary difference, unused tax losses and unused tax credits [abstract]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets and liabilities [abstract]
Deferred tax assets
16,354,000 EUR
63,456,000 EUR
Deferred tax liabilities
4 420 EUR
6 089 EUR
Reconciliation of accounting profit multiplied by applicable tax rates [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.